H1B Salary Data

Home › Employers › Boz Life Science Research and Teaching Institute

Boz Life Science Research and Teaching Institute: H-1B salaries and sponsorship

Boz Life Science Research and Teaching Institute filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $51,917.

Applications (LCAs)3
Certified3
Employer addressSan Diego, CA
H-1B dependent employerNo
Median offered salary$51,917
Middle half of salaries$51,917–$51,917
10th–90th percentile$51,917–$51,917

Does Boz Life Science Research and Teaching Institute sponsor H-1B visas?

Boz Life Science Research and Teaching Institute filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Aug 19, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Research Associate3$51,917

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$51,917
FY20252—

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Research Associate$55,557
part-time · Level I
La Jolla, CAAug 19, 2025Aug 20, 2025Certified
Research Associate$57,013
part-time · Level I
San Diego, CAJun 26, 2025Jun 30, 2025Certified
Research Associate$51,917
Level II
San Diego, CANov 9, 2022Nov 14, 2022Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).